Martin Shkreli at jury selection before fraud trial — SKETCHES OF COURT

Paterniano Del Favero
Giugno 28, 2017

One potential juror reported that both of his parents take Daraprim, according to the Times. He went on Twitter to label members of Congress "imbeciles" for demanding to know why his company, Turing Pharmaceuticals, raised the price of Daraprim, a drug used to treat toxoplasmosis and HIV, from $13.50 to $750 per pill.

On Monday, potential jurors in the trial ruled themselves out, saying they would be unable to be impartial when reaching a decision regarding the innocence or guilt of the former pharmaceutical executive in a fraud case. "They're struggling to pay" for their daily medical routine. Another said he's "the most hated man in America".

A second man said, "This is the price gouger of drugs". "My kids are on some of these drugs". An eight-count indictment accuses Shkreli of several acts of fraud relating to two hedge funds he previously led as well as the steep price hikes on drugs he approved as the head of a biotechnology start-up.

"Who does that?" she said. "A person who puts profits ahead of everyone else".

While Shkreli is charged for securities fraud, Assistant US Attorney Alexandra Smith said jurors may hear about Skreli's handling of Daraprin during the trial. One potential juror said, "He's a snake".

One said she had not known what the trial was about when she walked in and saw Shkreli.

"Who does that?" the woman said.

At the jury selection in a Brooklyn courtroom, more than 100 potential jurors were dismissed.

Barring a pool reporter, the lawyer said, "Will not stop people from having bad views of Mr. Shkreli".

"I'm anticipating an article, a piece, that will further complicate the already complicated job of defending someone so many people feel strongly about", he said.

"I have total disdain for the man".

Prosecutors say Shkreli misled investors about the size and performance of MSMB Capital Management, claiming that its returns were "+35.77% since inception" - when the fund had actually lost 18 percent. "I would never convict him", she said.

At least three other jurors mistakenly believed Shkreli was responsible for raising the cost of EpiPen - an allergy injection - and could therefore not be fair toward him. Many were excused because of work, vacation and other engagements. About two-thirds of roughly 90 prospective jurors questioned in the morning session were dismissed.

Jury selection has begun for the pharmaceutical businessman Martin Shkreli.

Altre relazioni OverNewsmagazine

Discuti questo articolo

SEGUI I NOSTRI GIORNALE